Genentech Team Uses Hybrid Approach to ID Novel Somatic Mutations, Potential Drug Targets in Tumors

The team used a variety of methods, including mismatch repair detection technology, sequencing on Roche's 454 GS FLX, and array-CGH, to identify thousands of novel somatic mutations.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.